Clinical Trial Update: Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating disitamab vedotin in combination with gemcitabine as neoadjuvant therapy for urothelial carcinoma undergoing radical cyst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Chunguang yang (101937) | Conditions: Radical Cystectomy, Urothelial Carcinoma | Phase 4 | Status: UNKNOWN